Statement: patients diagnosed with hormone receptor negative early stage breast cancer are eligible for the primary clinical trial, regardless of their previous treatment history.
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).